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Spontaneous purinergic neurotransmission in the mouse
urinary bladder
John S. Young1, En Meng1,2, Tom C. Cunnane1 and Keith L. Brain1
1Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK
2Division of Urology, Department of Surgery, Tri-Service General Hospital, no. 325, Sec. 2, Chenggong Road, Neihu, Taipei 114, Taiwan, ROC
Spontaneous purinergic neurotransmission was characterized in the mouse urinary bladder, a
model for thepathological or ageinghumanbladder. Intracellular electrophysiological recording
from smooth muscle cells of the detrusor muscle revealed spontaneous depolarizations,
distinguishable from spontaneous action potentials (sAPs) by their amplitude (< 40mV) and
insensitivity to the L-type Ca2+ channel blocker nifedipine (1 μm) (100± 29%). Spontaneous
depolarizations were abolished by the P2X1 receptor antagonist NF449 (10μm) (frequency
8.5± 8.5% of controls), insensitive to themuscarinic acetylcholine receptor antagonist atropine
(1μm) (103.4± 3.0%), and became more frequent in latrotoxin (LTX; 1 nm) (438± 95%),
suggesting that they are spontaneous excitatory junction potentials (sEJPs). Such sEJPs were
correlated, in amplitude and timing,with focalCa2+ transients in smoothmuscle cells (measured
using confocal microscopy), suggesting a common origin: ATP binding to P2X1 receptors. sAPs
were abolishedbyNF449, insensitive to atropine (126± 39%) and increased in frequencybyLTX
(930± 450%) suggesting a neurogenic, purinergic origin, in commonwith sEJPs. By comparing
the kinetics of sAPs and sEJPs, we demonstrated that sAPs occur when sufficient cation influx
through P2X1 receptors triggers L-type Ca2+ channels; the first peak of the differentiated rising
phase of depolarizations – attributed to the influx of cations through the P2X1 receptor – is
of larger amplitude for sAPs (2248mV s−1) than sEJPs (439mV s−1). Surprisingly, sAPs in the
mouse urinary bladder, unlike those from other species, are triggered by stochastic ATP release
from parasympathetic nerve terminals rather than being myogenic.
(Received 21 August 2008; accepted after revision 12 October 2008; first published online 20 October 2008)
Corresponding author J. S. Young: Department of Pharmacology, University of Oxford, Mansfield Road,
Oxford OX1 3QT, UK. Email: john.s.young@gmail.com
Inmostmammals, excitation of the detrusormuscle of the
urinary bladder is achieved through the parasympathetic
activation of both purinergic and cholinergic
neurotransmission, leading to voiding of the bladder. The
brief, initial phase of contraction is atropine insensitive
(Henderson & Roepke, 1934) and purinergic (Burnstock
et al. 1978); the second phase, of longer duration, is
cholinergic (Krell et al. 1981). The balance between
purinergic and cholinergic neurotransmission observed
experimentally varies widely. This variation is often
attributed to the following three factors. (i) Species
used. Detrusor contraction is almost entirely controlled
by purinergic neurotransmission in cat (Nerga˚rdh,
1981) and rabbit (Sibley, 1984), whereas cholinergic
neurotransmission dominates in the Old World primates
(Craggs & Stephenson, 1985). (ii) Age. For example, there
is an increase with age in the contribution of purinergic
This paper has online Supplemental material.
neurotransmission to bladder voiding in the human
(Yoshida et al. 2001) and rat (Saito et al. 1991). (iii)
Experimental protocol. Single pulse or low frequency,
repetitive transmural electrical stimulation evokes an
atropine-insensitive contraction (Ambache & Zar, 1970);
high frequency repetitive stimulation evokes excitation
that comprises a much larger proportion of cholinergic
than purinergic neurotransmission (Sibley, 1984).
Normal voiding of the human bladder is attributed
to the actions of acetylcholine as the primary excitatory
neurotransmitter. The administration of the muscarinic
cholinergic receptor antagonist atropine to healthy
subjects resulted indifficulty in initiating, andpainduring,
micturition (Cullumbine et al. 1955) and in some in
vitro studies, atropine was shown to abolish electrically
evoked contraction (Sjo¨rgen et al. 1982; Sibley, 1984).
There are other in vitro studies, however, which suggest a
role for purinergic neurotransmission in normal voiding;
Cowan & Daniel (1983), for example, demonstrated
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that atropine abolished only 50% of stimulated
contractions, and others (e.g. Elme´r et al. 1986;Hoyle et al.
1989; Luheshi & Zar, 1990) have shown atropine-resistant
contractions, albeit comprising a smaller proportion of
excitatory neurotransmission than is attributed to the
actions of acetylcholine. The wide variation in reported
contributions of purinergic neurotransmission to bladder
voiding ispartly explainedby themethodological difficulty
of evoking neural stimulation without also evoking
potentiallymasking directmuscle stimulation (Hoyle et al.
1989). It is, however, generally agreed that purinergic
neurotransmission is up-regulated inbladder dysfunction;
Sjo¨rgen et al. (1982) demonstrated, for example, that
while atropine abolished contractions in preparations
from normal bladders, preparations from pathological
bladders exhibited contractions that were up to 50%
atropine resistant.
It has been demonstrated that ATP, released from
parasympathetic nerve terminals, binds to P2X receptors
(Burnstock & Kennedy, 1985; Howson et al. 1988) on
urinary bladder smooth muscle cells (SMCs), producing
an excitatory junction potential (EJP) that triggers the
opening of L-type Ca2+ channels and the subsequent
initiation of an action potential (Hoyle & Burnstock,
1985; Howson et al. 1988). Heppner et al. (2005) recently
identified purinergic focal Ca2+ transients, corresponding
to the influx of Ca2+ through P2X receptors upon ATP
binding in rat urinary bladder smooth muscle.
In summary, although purines may not be the
major excitatory neurotransmitters responsible for
human bladder voiding, their up-regulated role in
pathological states and with ageing makes purinergic
neurotransmission a key area of study. The aims of the
present study are to: (i) use simultaneous electro-
physiological recording of membrane potential
and high-speed imaging of Ca2+ fluorescence to
determine whether a relationship exists between
spontaneous purinergic Ca2+ transients and spontaneous
depolarizations inmouse urinary bladder smoothmuscle,
and (ii) to characterize spontaneous depolarizations and,
in particular, to determine the mechanisms underlying
their generation.
Methods
General
Mice of the C57BL/6 strain, of either sex, weighing
18–30 g, were killed by head concussion followed by
cervical dislocation. Efforts were made to minimize
the number of animals used and their suffering; all
experiments were carried out in accordance with the UK
Animals (Scientific Procedures) Act 1986 and European
Communities Council Directive 86/09/EEC.
The urinary bladder was removed and its ventral
wall was opened longitudinally from the bladder neck
(posterior) to the top of the dome (anterior). The
urothelium was removed by careful dissection using iris
scissors; carewas takennot to stretch or damage the under-
lying detrusor muscle. Tissue strips, which contained
a few bundles of smooth muscle, 6–8mm long and
1–2mm wide, were cut along the craniocaudal axis of
the dorsal surface of the detrusor. Strips were pinned
out on a Sylgard (Dow Corning Corporation, Midland,
MI, USA)-lined plate at the bottom of a shallow chamber
(volume, approximately 1 ml), which wasmounted on the
stage of an upright microscope. Preparations were super-
fused with warmed (35◦C) physiological saline solution
(PSS) (composition, mM: NaCl, 120; KCl, 5.9; MgCl2, 1.2;
CaCl2 2.5;NaHCO3, 15.5;NaH2PO4, 1.2 andglucose, 11.5;
gassed with 95% O2 and 5% CO2) at a constant flow rate
(100ml h−1), maintaining a pH of 7.2–7.3 (Hashitani &
Brading, 2003). Preparations, when pinned, were allowed
to equilibrate (i.e. to accommodate under tension) for at
least 30min before electrophysiological recording or Ca2+
imaging.
Electrophysiological recordings
Individual bladder smoothmuscle cells in muscle bundles
were impaled with glass capillary microelectrodes, filled
with 0.5 M KCl (tip resistance, 100–300M). Membrane
potential changes were recorded using a high input
impedance amplifier (Axoclamp-2B, Axon Instruments,
Inc., Sunnyvale, CA, USA) and displayed on a digital
oscilloscope (DSO 1602, Gould, Ilford, UK). Membrane
potential changes were digitized using PowerLab/4SP
(ADInstruments, Chalgrove, UK) at 4 kHz and stored on
computer for later analysis.
Recordings were made from a minimum of six cells,
for at least 5 min each, in the absence of drugs (‘control’
measurements). One long, continuous recording was then
made, which included a control period (typically 10min),
and then a period (up to 1 h) in the presence of the drug.
Recordingswere subsequentlymade froma further six cells
(minimum), for at least 5 min each. Subsequent analysis of
the effect of the superfused reagents compared themedian
frequency for all cells recorded in the control period with
the median frequency of events in the presence of the
reagent, in a paired comparison.
Ca2+ imaging and analysis
Each detrusor strip was exposed to 10μM Oregon
Green 488 BAPTA-1 AM (Invitrogen, Paisley, UK) in 1%
DMSO–0.2% Pluronic F-127 (Sigma-Aldrich, St Louis,
MO, USA) in physiological salt solution (PSS) for 70min
at 36◦C. The tissue was rinsed in PSS, bubbled with 95%
O2–5% CO2, for at least 10min. Tissues were pinned flat,
C© 2008 The Authors. Journal compilation C© 2008 The Physiological Society
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serosal sideup, in aSylgard-linedorganbath, andmounted
on the stage of an upright confocal microscope (Leica SP2
upright confocal microscope; Leica Microsystems, Milton
Keynes, UK).
A series of 200 frames was captured at 13.5 Hz to
generate one image set. Such sets were acquired once every
minute. Ten sets were generated for each region of the
preparation, with at least three regions sampled per drug
treatment and/or preparation.
Microelectrodes used for simultaneous confocal
recordings (tip resistances of 200–300M) were filled
with a potassium salt of Oregon Green BAPTA-1 (100μM
in 0.5 M potassium acetate; weight 10 kDa; Invitrogen).
The microelectrode tip (or part of it) was always within
the field of view of the confocal image.
Image analysis was performed using plug-ins for
ImageJ (http://rsb.info.nih.gov/ij/download.html) that
were custom-written by Dr R. J. Amos to detect focal
increases in fluorescence of the Ca2+ indicator. Data were
exported to Excel (Microsoft, Redmond, WA, USA) for
formatting and then to Spike 2 (Cambridge Electronic
Design, Cambridge, UK) for analysis in conjunction with
electrophysiological recordings.
Analysis of correlations between focal Ca2+ transients
and spontaneous depolarizations
The peak amplitudes of focal Ca2+ transients and
spontaneous depolarizations were calculated using a
custom-written script for Spike 2. The threshold for
determining focal Ca2+ transients varied between
recordings in different SMCs. The threshold was adjusted
until it provided specificity comparable to manual
counting (F/F range of 0.06–0.1).
Occasionally, > 1 coincident focal Ca2+ transient was
observed within the impaled cell. In this instance, the
amplitudes of spontaneous depolarizations and focal Ca2+
transients were not included in the subsequent analysis.
In order to estimate the time of initiation of focal
Ca2+ transients, experiments were performed in which
Ca2+ fluorescence was measured along the long axis
of a SMC at a high acquisition rate (2 kHz) and
the amplitudes and timing of focal Ca2+ transients
were correlated with the membrane potential of the
imaged cell, simultaneouslymeasuredusing thepreviously
described electrophysiological recording technique. Ca2+
fluorescence was measured in a 20μm-wide window
around each focal Ca2+ transient for the duration of each
acquisition period (approx. 2 s) using ImageJ. Using a
custom-written script for R (http://www.r-project.org) a
curve was then fitted, comprising:
y = Co (the resting fluorescence), before the initiation of
the focal Ca2+ transient (i.e. t < t o), and
y = Co + A
(
e−k1[t−to] − e−k2[t−to]) , thereafter (i.e. t ≥ to).
A is an arbritrary constant.
The time of initiation (t o) was that giving theminimum
residual sum of squares for this curve fit. This function
arises from a simple model of Ca2+ influx through P2X1
receptors, with Ca2+ then cleared by a first-order process
(see Appendix).
Drug sources, preparation and application
Tetrodotoxin (Tocris, Bristol, UK), nifedipine (Bayer,
Leverkusen, North Rhine-Westphalia, Germany) and
atropine sulphate (VWR; Lutterworth, UK) were stored
frozen (−20◦C) at a concentration of 10mM in DMSO.
NF449 (at 1 mM; Tocris, Bristol, UK) and α-latrotoxin
(at 300 nM; Sigma-Aldrich) were stored frozen in distilled
water. Drugs were diluted to their final concentration in
PSS and applied to the preparation by switching the super-
fusate from standard PSS.
Statistical analysis
The normality and homogeneity of variance was
tested prior to further statistical analysis using
Kolmogorov–Smirnov and Levene’s tests, respectively
(SPSS version 11, SPSS Inc., Chicago, IL, USA). Unless
otherwise stated, statistical comparisons are Student’s
two-tailed paired t test. The term n, used in the
presentation of statistical analyses throughout, refers to
the number of animals used.
Results
Pharmacology of spontaneous depolarizations
Intracellular recording of smooth muscle cells in the
mouse urinary bladder revealed both spontaneous
depolarizations (sDeps) and spontaneous action
potentials (sAPs), as previously described. sAPs
can be distinguished from sDeps by their greater
amplitude, the presence of an after-hyperpolarization
or after-depolarization and their sensitivity to the
voltage-dependent Ca2+ channel (VDCC) antagonist
nifedipine (Meng et al. 2008).
In order to determine the mechanisms underlying
the generation of sDeps, the contributions of purinergic
and cholinergic neurotransmissionwere explored through
the application of specific antagonists. The purinergic
P2X1 antagonist NF449 (10μM) greatly reduced the
frequency of sDeps. The frequency at which sDeps
were detected was reduced from 8.0± 3.6 min−1 in
control cells to 0.7± 0.3 min−1 following 1 h of
superfusion with NF449 (post-NF449, 8.5± 8.5% of
controls; P < 0.01, n= 4; Fig. 1Aa and B), with
the amplitude of the remaining events reduced to
75± 6% of controls (P < 0.05, n= 4). Superfusion
of the P2X1-desensitizing agonist α,β-methylene ATP
C© 2008 The Authors. Journal compilation C© 2008 The Physiological Society
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Figure 1. Spontaneous depolarizations (sDeps) are purinergic in
origin
A, comparing the effects of the superfusion of the P2X1 antagonist
NF449 (10 μM) (a), the P2X1-desensitizing agent α,β-methylene ATP
(α,β-mATP; 1 μM) (b), the muscarinic acetylcholine receptor antagonist
atropine (1 μM) (c), a blocker of Na+ channels, tetrodotoxin (TTX,
1 μM) (d) and an antagonist of L-type Ca2+ channels, nifedipine
(1 μM) (e) on the membrane potential of SMCs. Note the longer
time-scale of Ab. A depolarization and increase in the sAP frequency
induced by α,β-mATP (Ab) is initially noted (consistent with its action
as an agonist), before the membrane potential returns towards its
resting level and the sAPs decline in frequency (presumably as the
receptors desensitize). B, a comparison of the frequency of sDeps for
each drug application to normalized control frequencies, with paired
t test statistical comparisons (see text for details).
(α,β-mATP; 1μM) reduced the frequency with which
sDeps were detected from 11.3± 2.0 min−1 in control
cells to 1.4± 0.6 min−1 (post-α,β-mATP, 11.4± 0.6%;
P < 0.01, n= 4; Fig. 1Ab and B) with the amplitude
of remaining sDeps reduced to 55± 10% of controls
(P < 0.05, n= 4). In contrast to NF449 and α,β-mATP,
the muscarinic acetylcholine receptor antagonist atropine
(1μM) did not affect the frequency of sDeps, which
was 74± 31min−1 in control cells and 76± 31min−1
following 1 h application (post-atropine, 103.4± 2.6% of
controls; P = not significant (NS), n= 4; Fig. 1Ac and B).
In the urinary bladder of the guinea pig, it has
been reported that some large-amplitude sEJPs result
from spontaneous nerve terminal action potentials
(Bramich & Brading, 1996). In the present work in
mouse urinary bladder, however, TTX (1μM) did
not abolish large-amplitude (> 10mV) sDeps (range,
control: 1.7–35.0 mV; TTX, following superfusion for 1 h:
1.4–31.2 mV, n= 4). TTX (1μM) also did not affect the
frequency of sDeps, which was 4.3± 0.5 min−1 in control
cells, and 7.1± 1.1 min−1 following TTX (post-TTX,
166± 55% of controls; P =NS; Fig. 1Ad and B).
In order to determine whether blocking L-type Ca2+
channels affected the frequency at which sDeps were
detected, the effect of nifedipine was assessed. Nifedipine
(1μM) did not affect the frequency of sDeps, which
was 6.6± 2.3 min−1 in control cells, and 6.5± 2.0 min−1
following nifedipine superfusion for 1 h (post-nifedipine,
100± 29% of controls; P =NS; Fig. 1Ae and B).
In order to determine whether the ATP that initiates
sDeps comes from nerves, experiments were performed
in the presence of an extract of the black widow
spider venom, α-latrotoxin (LTX), which increases
the rate of spontaneous neurotransmitter release from
nerve terminals. Superfusion of LTX (1 nM) for 10min
produced a 438± 95% increase in sDep frequency
(to 35.3± 8.3 min−1) with respect to the control
period (9.3± 2.6 min−1) (P < 0.05, n= 4; Fig. 2A). The
superfusion of atropine (1μM), in addition to LTX
(1 nM), produced a similarly large augmentation of sDeps,
to 460± 320% (63± 13min−1) of control frequency
(13.8± 2.8 min−1) (P < 0.05, n= 4; Fig. 2B). By contrast,
when LTX (1 nM) was superfused in addition to NF449
(10μM) sDeps were completely abolished within 15min
(n= 4; Fig. 2C).
Pharmacology of spontaneous action potentials
Spontaneous action potentials (sAPs; of amplitude:
53.4± 2mV) were observed in 38% of SMCs (i.e. 11 of
29, from n= 4) where they typically occurred at a low
frequency (0.77± 0.20min−1, range: 0.2–2.6). Following
superfusion of the P2X1 antagonistNF449 (10μM) for 1 h,
sAPs were not observed in any SMC (i.e. 28 of 28, from
C© 2008 The Authors. Journal compilation C© 2008 The Physiological Society
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n= 4). To confirm that NF449 had no direct effect on
L-type Ca2+ channels, SMC membrane properties were
examined with a series of brief current injections. In
control cells and those superfused with NF449 (10μM)
for 1 h, current injections ≥ +0.09 nA stimulated active
currents consistent with normal opening of L-type Ca2+
channels (see online Supplemental material, Fig. 1).
Superfusion of the P2X1-desensitizing agent α,β-mATP
(1μM) reduced the number of SMCs in which sAPs were
observed from 17 of 25 (from n= 4) in control cells to 4
of 20 following α,β-mATP superfusion (Fisher’s exact test
P < 0.05). The frequency of sAPs occurring in cells that
had at least one sAP was reduced from 1.17± 0.44min−1
in control cells to 0.141± 0.009min−1 (P < 0.05, n= 4).
By contrast to the effects of NF449 and α,β-mATP,
the muscarinic acetylcholine receptor antagonist atropine
(1μM) did not affect the frequency of sAPs, which was
0.54± 0.37min−1 in control cells and 0.89± 0.58min−1
following 1 h application (post-atropine, 126± 39% of
controls; P =NS, n= 4).
In order to determine the contribution of spontaneous
activation of nerve branches or spontaneous nerve
terminal action potentials to sAPs, the frequency of sAPs
was compared following superfusion of TTX (1μM).
The frequency of sAPs was similar in control cells
(0.52± 0.3 min−1, range: 0.1–2.1; observed in 6 of 28
SMCs, from n= 4) to those superfused with TTX for
1 h (0.73± 0.40min−1, range: 0.1–2.1; observed in 7
of 28 SMCs, from n= 4) (P =NS, Student’s t test).
The amplitudes of sAPs were unaffected by TTX super-
fusion (control: 50.1± 3.0 mV, post-TTX: 51.5± 2.0 mV;
P =NS, Student’s t test).
In order to investigate whether sAPs result from
nerve-released ATP, experiments were performed in the
presence of LTX. Following the superfusion of LTX (1 nM)
for 10min, sAP frequency was increased to 930± 450% of
control (i.e. 1.9± 0.5 min−1 to11.0± 3.1 min−1;P < 0.05,
n= 4). sAPs were also increased in frequency following
superfusion of LTX and atropine (1μM) (600± 370% of
control; from 0.4± 0.1 min−1 to 2.8± 1.8 min−1; P =NS,
n= 3), but sAPs were abolished by LTX and NF449
(10μM) (9± 5% of control; from 1.5± 0.6 min−1 to
0.1 min−1; P < 0.001, n= 4).
The relationship between sDeps and sAPs
To determine whether sDeps might intermittently initiate
sAPs, their kinetics were compared. Both sDeps and sAPs
occurred with variable rising phases, with times-to-peak
ranging from 5 to 89ms for sDeps (median: 30ms, no.
of events= 4755, e.g. Fig. 3A) and 11–49ms for sAPs
(median: 19ms, no. of events= 369, e.g. Fig. 3B). In
order to test the hypothesis that the more prolonged
rise times of sDeps indicate a lower peak current after
ATP binding to P2X1 receptors, the rising phases of both
sDeps and sAPs were differentiated and compared. The
differentiated rising phases of sDeps usually contained one
peak, which varied in amplitude with a positively skewed
distribution from 0.4 to 4.5 V s−1 (Fig. 3A). By contrast,
the differentiated rising phase of sAPs always contained
two determinable peaks and the broad amplitude
frequency distribution (0.6–6.3 V s−1) of the first peak is
consistent with the highly variable time-to-peak of sAPs
(Fig. 3B). Comparing the first peak of the differentiated
rising phase of the depolarization revealed that the
amplitude of the first derivative was much greater
for sAPs (median: 2248mV s−1, range: 454–4913) than
sDeps (median: 439mV s−1, range: 334–950) (P < 0.0001,
n= 12, Wilcoxon signed rank test; Fig. 3C).
The L-type Ca2+ channel antagonist nifedipine
(1μM) abolished sAPs (Fig. 4A), and thus removed all
depolarizations > 40mV (Fig. 4B). We wanted to test
the hypothesis that a subpopulation of large-amplitude
depolarizations may trigger sAPs. If so, nifedipine
should reveal a subpopulation of large-amplitude
sDeps. No such subpopulation of large amplitude (e.g.
30–40mV) sDeps was observed (e.g. data from a single,
long-duration recording. Control, median amplitude:
8.8 mV, interquartile range: 6–13mV; post-nifedipine:
8.1 mV, 6–14mV; no. of sDeps was 996 and 355 for the
Control LTX (1 nM)
Control LTX (1 nM) + atropine (1 μM)
20 mV
5 s
Control LTX (1 nM) + NF449 (10 μM)
A
B
C
Figure 2. Spontaneous depolarizations are neurogenic
A, α-latrotoxin (LTX; 1 nM), which serves to increase the rate of
spontaneous neurotransmitter release, caused an increase in the
frequency of sDeps and spontaneous action potentials (sAPs).
B, similarly, the superfusion of LTX and atropine (1 μM) produced a
marked increase in the frequency of sDeps and sAPs. C, superfusion of
LTX in combination with NF449 (10 μM), however, abolished all
depolarizations. Data shown (i.e. control, then following 15 min drug
superfusion) are excerpts from continuous recordings.
C© 2008 The Authors. Journal compilation C© 2008 The Physiological Society
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Figure 3. Peaks in the differentiated rising phases of sAPs are
of, on average, larger amplitude than the differentiated peaks
of sDeps
A, sDeps (grey trace) occurred with variable rising phases. When
differentiated (black trace), peaks (arrows) occurred with a positively
control and post-nifedipine periods, respectively. P =NS,
Mann–Whitney U test) (Fig. 4B).
However, the peak inward current through P2X1
receptors might provide a more sensitive measure of
transmitter release than the amplitude of sDeps. To
assess the inward current through P2X1 receptors, the
differentiated rising phases of only sDeps, pre- and
post-superfusion with nifedipine (1μM), were compared.
The amplitude of the first derivative of the sDep increased
from 237mV s−1 in control cells (median amplitude;
range: 182–359) to 268mV s−1 (range: 196–422) following
nifedipine superfusion (i.e. to 113± 3% of controls;
Student’s one-tailed paired t test, P < 0.05, n= 4) (data
shown for one experiment, Fig. 4C). In control cells of
these experiments, sAPs represented 12% (range: 3–21) of
all depolarizations.
The relationship between spontaneous
depolarizations and focal Ca2+ transients
Loading detrusor smooth muscle with the Ca2+
indicator Oregon Green BAPTA-1 AM revealed three
types of spontaneous Ca2+ transient (whole-cell Ca2+
flashes, Ca2+ waves and focal Ca2+ transients), as
reported by Meng et al. (2008). Simultaneous electro-
physiology and confocal imaging of Ca2+ indicator
fluorescence was used to determine the relationship
between spontaneous depolarizations (sDeps) of the
membrane potential of SMCs, with spontaneous focal,
transient increases in fluorescence. Focal Ca2+ transients
(Fig. 5A) were coincident with sDeps (Fig. 5B and C).
The relationship between these two events was explored
with higher temporal resolution (2 kHz), by correlating
line-scans taken along the long axis of a SMC (Fig. 6A),
with a simultaneous measure of the membrane potential,
recorded with an intracellular electrode impaled in the
imaged cell. A focalCa2+ transient occurred as a local event
along the x-axis of the line-scan (Fig. 6B). Ameasure of the
intensity of the Ca2+ fluorescence for this region revealed a
rapid rise in [Ca2+] over a period of approximately 100ms,
and then a slow decline to baseline (Fig. 6C). For the same
period of time and in the same cell, a sDep was observed
that exhibits a rise-to-peak amplitude and time course of
skewed amplitude distribution. B, sAPs (grey trace), which occurred
with similarly varying waveforms as sDeps, reveal two peaks (arrows)
when differentiated (black trace); the amplitude of the first peak of
which has a broad amplitude distribution. Data shown for A and B are
from a single, long-duration recording. Bin sizes for the amplitude
distributions of first derivatives are 0.125 V s−1. Note that the scale
bars associated with the raw data of A and B are of differing
magnitudes, and that the differentiated sAPs (B) are truncated at
–1 V s−1. C, the median amplitude of the first peak of the
differentiated sAP is greater than the amplitude of the differentiated
sDep. Data are median, quartiles and range (n = 12). See text for
details of statistical comparison.
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decay that wasmuchmore rapid than the concurrent focal
Ca2+ transient (459ms; median half-decay time: 568ms,
range 329–921; n= 3). Expanding the scale (Fig. 6D), the
rise in [Ca2+] starts approximately 8 ms after the initiation
of the sDep. The latency of rise in [Ca2+] relative to the
initiation of a sDep was calculated for 12 events occurring
in preparations from three animals. The median latency
was 10.4 ms (range: 4.3–25.8 ms).
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Figure 4. Blocking sAPs, through the application of nifedipine,
reveals a subpopulation of sDeps with an especially rapid rising
phase
A, superfusion of nifedipine (1 μM; 15 min superfusion) abolished
sAPs in murine detrusor smooth muscle. A spontaneous depolarization
with a following prolonged hyperpolarization was incidentally
observed in the trace in the presence of nifedipine; such events were
also occasionally observed in control cells (not shown) and have not
been further characterized. Data shown are from a continuous
recording. B, the amplitude frequency distribution post-nifedipine
does not reveal a subpopulation of large amplitude sDeps; only the
loss of depolarizations > 40 mV in amplitude. The threshold for
detecting sEJPs was 2 mV. C, differentiated rising phases of sDeps
reveal an increase in the frequency of larger amplitude events
following nifedipine (1 μM) superfusion, compared to a control period.
The model fit to the Ca2+ signal (e.g. Fig. 6D) is based
on an exponentially declining calcium influx, which is
then removed by a first-order process. The change in
membrane potential is proportional to the number of
P2X receptors open (i.e. the conductance change) and
Figure 5. Spontaneous focal Ca2+ transients are coincident with
spontaneous depolarizations (sDeps) in mouse urinary bladder
smooth muscle
A, a region of a smooth muscle cell (SMC) in a mouse isolated urinary
bladder (loaded with the Ca2+ indicator Oregon Green 488 BAPTA-1
AM) during an intracellular recording. Images, acquired at 13.5 Hz, are
4 consecutive frames of a 200 frame series. A spontaneous focal Ca2+
transient occurred on frame ii (arrowhead). B, intracellular recording of
a period that includes the same four frames that compose A, showing
simultaneous recordings of membrane potential (black line) and
whole-cell fluorescence (grey dots). C, simultaneous Ca2+ imaging
and electrophysiology demonstrate the coincidence of focal Ca2+
transients and sDeps during a longer period.
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hence to the rate of Ca2+ influx (see Appendix). The sEJP
fall time (median: 40ms, interquartile range: 30–44ms,
calculated for 12 events which occurred in preparations
from 3 animals) was similar to the estimate of the rate
of Ca2+ influx, 1/k2 (median: 42ms, 30–75ms). There
was no significant difference in the median time course of
the sEJP and the modelled Ca2+ influx (1/k2) (P =NS,
Mann–Whitney U test), although these two measures
were not correlated on a pair-wise basis (Spearman rank
correlation, ρ = −0.23, and P =NS).
In addition to the temporal correlation, there was also a
correlation in the amplitudes of focal Ca2+ transients and
sDeps, both for large and small amplitude events (Pearson
product moment correlation, ρ > 0.41 and P < 0.05 for
each of n= 3 experiments; Fig. 7).
Whole-cell Ca2+ flashes and Ca2+ waves were also
observed during simultaneous recordings, but both events
occurred infrequently. Whole-cell Ca2+ flashes were
observed to be concurrent with sAPs but Ca2+ waves did
not correlate with any changes of the membrane potential
of the impaled SMC.
In order to establish whether focal Ca2+ transients
were associated with nerve terminal varicosities,
parasympathetic neurones were visualized using the
fluorescent dye, 3,3-diethyloxardicarbocyanine iodide
(DiOC2(5); Yoshikami & Okun, 1984). Focal Ca2+ trans-
ients were observed close to nerve terminal varicosities
(e.g. online Supplemental movie).
Discussion
Purinergic neurotransmission in the detrusor muscle of
the human urinary bladder is up-regulated in pathological
states (Palea et al. 1993) and with ageing (Yoshida et al.
2001). The mouse is an ideal model for the study of
purinergic neurotransmission due to the relative ease
with which transgenic animals can be produced (e.g.
Vial & Evans, 2000) and because purinergic neuro-
Figure 6. Simultaneous Ca2+ imaging and electrophysiological
measurement at a higher temporal resolution of imaging reveal
the temporal relationship between focal Ca2+ transients and
sDeps
A, a region of a smooth muscle cell (SMC) in a mouse isolated urinary
bladder (loaded with the Ca2+ indicator Oregon Green 488
BAPTA-1 AM) during an intracellular recording. Line scans were taken
along the long axis of an impaled SMC, the position of which is
denoted by the dashed white line. B, line scan, acquired at 2 kHz, of
the SMC (A) showing the occurrence of a focal Ca2+ transient (arrow).
C, a measure of the Ca2+ fluorescence for a 20 μm region of the SMC
in which the focal Ca2+ transient occurs (grey) compared to the
membrane potential of the same cell for the same period of time
(black). D, the occurrence of the focal Ca2+ transient (grey) and sDep
(black) shown on an expanded time scale. The dark grey line of Ca2+
fluorescence (C and D) is a curve fitted using a custom-written script;
see Methods for details.
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transmission is a major component of detrusor excitation
in this species (Holt et al. 1985; Meng et al. 2008).
Thus, the aim of the current study was to characterize
further spontaneous purinergic neurotransmission in the
mouse urinary bladder, by first determining the origin of
frequent ‘spontaneous depolarizations’ and spontaneous
action potentials in smooth muscle cells (SMCs), and
second to investigate their relationship to ‘purinergic Ca2+
transients’ (Heppner et al. 2005) identified in rat urinary
bladder smooth muscle cells.
Spontaneous depolarizations are neurogenic,
purinergic spontaneous excitatory junction potentials
ATP, released fromnerve terminals, acts on P2X1 receptors
to cause frequent spontaneous depolarizations (sDeps)
in the mouse urinary bladder. First, sDeps recorded
using intracellular electrophysiology from SMCs were
demonstrated to be purinergic in origin, consistent with
the study of Meng et al. (2008). In the present study,
sDeps were shown to be the result of ATP binding
to P2X1 receptors, as they were almost abolished by
the specific P2X1 receptor antagonist NF449 and the
desensitizing agonistα,β-mATP (Fig. 1B). This conclusion
is supported by the study of Vial & Evans (2000), in
which ATP-induced inward currents were not present
in bladder SMCs isolated from P2X1 receptor-deficient
mice. Also consistent with Meng et al. (2008) was the
insensitivity of sDeps to atropine (1μM; Fig. 1B). Second,
the ATP that causes sDeps was shown to be released from
nerve terminals. Following superfusion of α-latrotoxin
(LTX; 1 nM), an agent which stimulates spontaneous
neurotransmitter release (Ceccarelli & Hurlbut, 1980),
the frequency of sDeps increased markedly (Fig. 2A).
LTX-stimulated sDeps were abolished by NF449 (Fig. 2C)
but were insensitive to atropine (Fig. 2B), suggesting that
LTX did not stimulate acetylcholine release that, in turn,
stimulated ATP release from, for example, SMCs.
The possibility that sDeps could be generated by
spontaneous transient inward currents (‘STICs’) seems
unlikely given that the time course of sDeps (49± 26ms;
Meng et al. 2008) is an order of magnitude briefer than
stretch-induced STICs in isolated SMCs (approx. 500ms;
Ji et al.2002).Thedetectionof the sDepsbefore theonset of
local Ca2+ transients (by about 10ms), also argues against
the Ca2+ transient activating a local ion conductance to
generate a depolarization.
It should also be noted that there is unlikely to be
any influence from urothelium-derived ATP (produced,
for example, in response to stretch; Burnstock, 2001) as
experiments were performed on muscle strips following
careful removal of the urothelium, and recordings were
made from the serosal surface.
The observations that sDeps were (i) increased in
frequency by LTX, (ii) unaffected by TTX, and (iii)
that their time course is very different to that of STICs
recorded from isolated myocytes, imply that sDeps are
the result of spontaneous neurotransmitter release from
nerve terminals and are therefore spontaneous excitatory
junction potentials (sEJPs).
Spontaneous action potentials (sAPs) are neurogenic
and purinergic
Spontaneous action potentials (sAPs) were demonstrated
to have a similar origin to sEJPs, i.e. nerve terminal-
releasedATP. sAPs, present in38%of control cells sampled,
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Figure 7. Focal Ca2+ transients and concurrent spontaneous
depolarizations are correlated in amplitude
Correlations are shown for three recordings in which there were
sufficient events to draw comparison of amplitudes.
Focal Ca2+ transient amplitude = F × areaFo , where F is the change
in fluorescence, Fo the resting fluorescence, and ‘area’ is the area over
which the fluorescent signal is measured (in pixels) divided by 32; this
is hence an arbitrary unit.
C© 2008 The Authors. Journal compilation C© 2008 The Physiological Society
5752 J. S. Young and others J Physiol 586.23
were not observed in any cells following the superfusion of
NF449 andwere almost abolished following P2X1 receptor
desensitization with α,β-mATP. By contrast, atropine
(1μM) did not affect the frequency of sAPs. These findings
suggest that sAP frequency at rest is driven by the action
of ATP on P2X1 receptors rather than by acetylcholine.
sAP frequency was not influenced by spontaneous
activation of nerve branches or spontaneous nerve
terminal action potentials, as the frequency of sAPs was
similar in control cells (0.52 min−1; observed in 6 of 28
SMCs) to those superfused with TTX for 1 h (0.73min−1;
observed in 7 of 28 SMCs). In order to investigate whether
sAPs result fromnerve terminal-releasedATP, experiments
were performed in the presence of LTX. Superfusion
of LTX (1 nM) for 10min increased sAP frequency to
930± 450% of control.
During the present series of experiments, the sAPs
had a broad range of rise times with a prominent
after-hyperpolarization, similar to the pacemaker-type
sAPs previously described (Meng et al. 2008). Very
few action potentials with only an after-depolarization
(previously described as spike-type) were observed; such
a difference might have arisen because the shallow angle
of incidence of the electrode used in present work
might select more superficial cells than the more vertical
electrode approach used by Meng, Young and Brading
(J. S. Young, personal observation). The shallow angle
of electrode approach is necessary for the simultaneous
Ca2+-imaging experiments, so simultaneous recordings
of a significant number of spike-type sAPs with Ca2+
measurements presents anunconquered technical hurdle.
The relationship between sEJPs and sAPs
It is likely that the EJP is the basis of urinary
bladder smooth muscle action potentials; weak electrical
stimulation evokes only an EJP, while stronger stimulation
evokes an action potential (e.g. Creed et al. 1983; Brading
& Mostwin, 1989).
Both sEJPs and sAPs occur with highly variable
times-to-peak, ranging from 5 to 89ms for sEJPs and
11–49ms for sAPs. The peak amplitude of the first-time
derivative of the rising phase is proportional to the
peak current into the cell (Young et al. 2007b), thus
in order to test the hypothesis that sAPs arise when
the P2X1 receptor current is high, the rising phases of
both sEJPs and sAPs were differentiated for comparison.
For a sAP, the differentiated rising phase revealed two
peaks; the first attributed to the influx of cations through
the P2X receptor, and second, the influx of Ca2+ ions
through VDCCs (Fig. 3B). Thus comparing only the
first peak of the differentiated rising phase of the
depolarization revealed that the amplitude of the first
derivative was much greater for sAPs than sEJPs. To
further assess whether VDCC opening is correlated with
the peak current into the cell through P2X1 receptors,
the differentiated rising phases of sEJPs were compared
pre- and post-VDCC blockade. There was a significant
increase in the amplitude of the first derivative following
nifedipine (1μM) superfusion. The magnitude of the
increase infirst-derivative amplitudes followingnifedipine
superfusion was, however, relatively small (13± 3%), but
this is consistent with sAPs representing only a small
proportion (12%) of the depolarizations observed.
An increase in the median first-derivative amplitude
following VDCC blockade, taken together with a greater
amplitude of the first derivative for sAPs than sDeps,
suggests that sAPs are generated when a large-amplitude
post-junctional response to spontaneous ATP release
from nerve terminals depolarizes the smooth muscle
membrane potential to the voltage threshold for L-type
Ca2+ channels.
Focal Ca2+ transients are concurrent with sEJPs
in mouse urinary bladder SMCs
Confocal imaging of Ca2+ fluorescence identified, for the
first time, frequent, spontaneous focal Ca2+ transients in
SMCsof themouseurinarybladder (Fig. 5A). These events
were similar in appearance and time course to purinergic
Ca2+ transients of SMCs of mouse vas deferens (Brain
et al. 2002), rat mesenteric arteries (Lamont &Wier, 2002)
and the rat urinary bladder (referred to there as ‘localized
Ca2+ transients’; Heppner et al. 2005). To determine the
relationship between the focal Ca2+ transients of the
mouse urinary bladder and sEJPs, simultaneous intra-
cellular electrophysiology and confocal imaging of Ca2+
fluorescence were performed. A temporal correlation
between focal Ca2+ transients and sEJPs (Fig. 5B and
C) was further examined at a high (2 kHz) resolution,
which revealed a 10.4± 3.3 ms delay between the onset
of a focal Ca2+ transient and a sEJP recorded from the
same SMC (Fig. 6D). This delay is of similar magnitude
to the delay at neuroeffector junctions of the mouse
vas deferens (6 ms; Brain et al. 2002) and rat urinary
bladder (12–16ms; Heppner et al. 2005). Binding of ATP
to P2X1 receptors generates an influx of Na+ ions and
Ca2+ ions (Isenberg et al. 1992; Evans et al. 1996), but it
is unlikely that these movements are genuinely separated
by 10ms in SMCs of the mouse urinary bladder. During
the first few milliseconds, the Ca2+ entering the cell is
located close to the P2X receptors; the high local Ca2+
concentration saturates the high-affinity Ca2+ indicator
so that the mean fluorescent signal underestimates the
meanCa2+ concentration during the initial period of Ca2+
entry. This non-linearity might account for at least part
of the estimated delay. High endogenous Ca2+ buffering
close to the plasma membrane would also induce such an
effect. It is also possible that calcium-induced calcium
release (CICR) augments the Ca2+ that enters the cell
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through the P2X1 receptor upon ATP binding, causing
the delay between the onsets of the sEJP and the focal
Ca2+ transient.CICRhas beendemonstrated to contribute
to purinergic Ca2+ transients in SMCs of the guinea-pig
urinary bladder (Imaizumi et al. 1998; Hashitani et al.
2000) andmouse vas deferens (Brain et al. 2003), but plays
little role in SMCs of the mesenteric arteries (Lamont &
Wier, 2002) or urinary bladder (Heppner et al. 2005) of
rat. The potential contribution by CICR to focal Ca2+
transients in mouse urinary bladder SMCs awaits further
experiments to inhibit CICR.
Focal Ca2+ transients correlate in amplitude
with concurrent sEJPs
In addition to temporal coupling, focal Ca2+ transients
and sEJPs were also correlated in amplitude throughout
the amplitude range (Fig. 7). It has been suggested that
spontaneous focal transients only arise from the release
of the contents of a subpopulation of synaptic vesicles,
giant dense-cored vesicles (Blair et al. 2003), rather than
all vesicle types. The correlation of focal Ca2+ transients
with even low-amplitude sEJPs, also observed in another
smooth muscle organ, the mouse vas deferens (Young
et al. 2007a), argues against this hypothesis. As argued
elsewhere (Young et al. 2007a), an amplitude correlation
of focal Ca2+ transients and sEJPs is contrary to the
hypothesis that the variable amplitude of sEJPs results
from the attenuation of depolarizations originating from
distant release sites on neighbouring SMCs (Tomita, 1970;
Purves, 1976). The hypothesis that the variable sEJP
amplitudes represent the effects of ATP on only the
impaled cell (Young et al. 2007a) is supported by the high
input resistances of SMCs (388± 83M) in this tissue
(Meng et al. 2008).
The observation that sEJP fall time (40ms) was similar
to the estimate of the rate of Ca2+ influx, 1/k2 (42ms)
argues that the focal Ca2+ transients and sEJPs within
a SMC are determined by a common mechanism – ion
conductance through P2X1 receptors.
As the focal Ca2+ transients described in the
present study were shown to be correlated in timing and
amplitude with sEJPs, themselves abolished by the P2X1
receptor antagonist NF449, it is likely that the focal Ca2+
transients are purinergic in origin. It is unlikely that the
focal Ca2+ transients observed are sparks, as their time
course (half-decay time, 568ms) was similar to purinergic
Ca2+ transients of rat urinary bladder smooth muscle
(112± 9ms; Heppner et al. 2005) and much greater
than that of sparks in urinary bladder smooth muscle
(34± 5ms, Heppner et al. 2005), mouse urinary bladder
myocytes (69± 9ms, Fritz et al. 2007) or vascular smooth
muscle (range from27ms,Mironneau et al.1996; to61ms,
Jaggar et al. 1998).
Whole-cell Ca2+ flashes correlate with sAPs
The present work confirms a correlation between
whole-cell Ca2+ flashes and sAPs. The whole-cell Ca2+
flashes seem to represent the same type of event described
as ‘global Ca2+ flashes’ in rat urinary bladder smooth
muscle cells (Heppner et al. 2005), as they have similar
spatial and temporal characteristics, are abolished when
L-type Ca2+ channels are blocked, and decreased in
frequency by P2X receptor inhibition or desensitization.
In both cases these Ca2+ transients arise as a consequence
of smooth muscle action potentials, commonly initiated
by the action of ATP on P2X receptors.
Conclusions
We have characterized spontaneous purinergic
neurotransmission in mouse urinary bladder smooth
muscle, demonstrating frequent sEJPs and sAPs that result
from nerve-released ATP binding to P2X1 receptors, sAPs
occurring when the P2X1 current is sufficient to trigger
L-type Ca2+ channel opening. sEJPs correlate in timing
and amplitude with focal Ca2+ transients, suggesting that
both events result from the same quanta of ATP binding
to P2X1 receptors and providing further evidence for a
variable effective post-junctional response to ATP binding
in electrically well-coupled smooth muscle. The present
study demonstrates that sAPs and sEJPs are triggered by
the stochastic release of ATP from parasympathetic nerve
terminals.
Appendix
In SMCs of many organs the time course of the sEJP is
determined by the rate at which P2X1 channels inactivate
(A˚strand et al. 1988). To model the Ca2+ kinetics in a
focal Ca2+ transient, consider the P2X1 receptors opening
rapidly at t = 0 and then closing stochastically with a time
constant of k2. It is hypothesized that the P2X1 receptor
is the primary, or only, conductance for Ca2+ under these
conditions. Hence, the Ca2+ influx also falls exponentially
with a rate constant of k2. Assume that Ca2+ is removed
from the cells by a first-order process with a rate constant
of k1, then the change in Ca2+ concentration (C) is given
by:
dC
dt
= Aoe−k2t − k1C (1)
whereAo is a constant proportional to Ca2+ influx at t= 0.
This has the solution (given the limiting case of C = 0 as t
goes to infinity):
C = Ao
(k2 − k1) (e
−k1t − e−k2t) (2)
This can be checked by substitution.
C© 2008 The Authors. Journal compilation C© 2008 The Physiological Society
5754 J. S. Young and others J Physiol 586.23
Fitting this function to experimentally obtained
line-scanning confocal microscopy data of smoothmuscle
Ca2+ during a focal Ca2+ transient allows k2 to be
calculated and compared with the known sEJP time
constant.
The time at the peak Ca2+ concentration (tmax; found
when dC/dt = 0) is:
tmax =
ln
(
k1
k2
)
(k1 − k2)
The peak Ca2+ concentration (Cmax) is hence found (by
substituting tmax into eqn (2)) to be:
Cmax = Ao
(k2 − k1)
((
k1
k2
) −k1
(k1−k2) −
(
k1
k2
) −k2
(k1−k2)
)
So, for constants k1 and k2, the peak Ca2+ concentration
(Cmax) is proportional to the number of P2X1 receptors
opened at t = 0 (as this is proportional to Ao).
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